Noliprel (Indapamide, Perindopril Arginine)

Perindopril arginine and indapamide, the active ingredients in Noliprel, are an ACE inhibitor and thiazide‑like diuretic combination presented as an oral tablet for systemic use. They treat essential hypertension in adult patients by lowering blood pressure through vasodilation and diuresis.

GNH USA supplies Noliprel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured product availability across regulated markets. The company adheres to stringent manufacturing and distribution standards, providing reliable access to this antihypertensive therapy for healthcare providers globally.

Noliprel, a fixed‑dose combination of an ACE inhibitor and a thiazide‑like diuretic, is indicated for conditions associated with elevated arterial pressure.

- Essential hypertension: reduces systolic and diastolic blood pressure in adult patients. - Hypertension with fluid retention: adds diuretic effect to control excess volume and lower pressure. - Hypertension in patients with diabetes or chronic kidney disease: provides ACE inhibition for renal protection while managing blood pressure. - Isolated systolic hypertension in the elderly: specifically lowers systolic pressure to reduce cardiovascular risk. - Resistant hypertension as adjunct therapy: complements other antihypertensives when monotherapy is insufficient.

Like all antihypertensive agents, Noliprel may be associated with adverse reactions that vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness, especially after the first doses. - Cough, a dry or irritating sensation in the throat. - Headache, mild to moderate intensity. - Fatigue or general weakness. - Increased urination or electrolyte imbalance (e.g., low potassium). - Gastrointestinal discomfort such as nausea or abdominal pain.

Serious or Rare Side Effects: - Severe hypotension leading to fainting or shock. - Angio‑edema involving swelling of the face, lips, tongue or airway. - Acute kidney injury or significant rise in serum creatinine. - Hyperkalemia, especially in patients with renal impairment. - Blood dyscrasias such as leukopenia or thrombocytopenia. - Severe skin reactions like Stevens‑Johnson syndrome.

When prescribing Noliprel, clinicians should evaluate patient history and monitor specific parameters to ensure safe use.

- Renal function: assess baseline creatinine and eGFR, adjust if impairment present. - Electrolytes: monitor serum potassium and sodium, especially when combined with other diuretics. - Hypotension risk: caution in patients prone to low blood pressure or on concurrent antihypertensives. - Pregnancy and lactation: avoid use unless benefits clearly outweigh potential risks, as safety data are limited. - Drug‑specific contraindications: do not use in patients with known hypersensitivity to ACE inhibitors or thiazide‑like diuretics. - Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Noliprel can interact with several medicines, altering its efficacy or increasing the risk of adverse events.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalaemia. - Lithium: increased lithium levels leading to toxicity. - NSAIDs (e.g., ibuprofen, naproxen): may blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Other antihypertensives (beta‑blockers, calcium channel blockers): may enhance hypotensive effect. - Antidiabetic agents (insulin, sulfonylureas): ACE inhibition can potentiate hypoglycaemia. - Corticosteroids: may reduce diuretic efficacy and affect electrolyte balance.